Cytochrome P450 epoxygenases, soluble epoxide hydrolase, and the regulation of cardiovascular inflammation.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Molecular and Cellular Cardiology

• Publication date

  2010-02-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.yjmcc.2009.10.022PMID 19891972PMCID PMC2813356
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inflammation in Atherosclerosis

  2012cited by this paper
• Epoxyeicosatrienoic acid prevents postischemic electrocardiogram abnormalities in an isolated heart model.

  2009cited by this paper
• Soluble epoxide hydrolase gene deletion attenuates renal injury and inflammation with DOCA-salt hypertension.

  2009cited by this paper
• Epoxyeicosatrienoic acids limit damage to mitochondrial function following stress in cardiac cells.

  2009cited by this paper
• Interaction Between P450 Eicosanoids and Nitric Oxide in the Control of Arterial Tone in Mice

  2009cited by this paper
• Selective Inhibitors of CYP2J2 Related to Terfenadine Exhibit Strong Activity against Human Cancers in Vitro and in Vivo

  2009cited by this paper
• Role of B-type natriuretic peptide in epoxyeicosatrienoic acid-mediated improved post-ischaemic recovery of heart contractile function.

  2009influential reference
• Protective actions of epoxyeicosatrienoic acid: dual targeting of cardiovascular PI3K and KATP channels.

  2009cited by this paper
• Inhibition of soluble epoxide hydrolase attenuated atherosclerosis, abdominal aortic aneurysm formation and dyslipidemia in apolipoprotein E deficient mice infused with angiotensin II

  2009cited by this paper
• Beneficial effects of soluble epoxide hydrolase inhibitors in myocardial infarction model: Insight gained using metabolomic approaches.

  2009cited by this paper
• EET displays anti-inflammatory effects in TNF-alpha stimulated human bronchi: putative role of CPI-17.

  2008cited by this paper
• Multiple antiapoptotic targets of the PI3K/Akt survival pathway are activated by epoxyeicosatrienoic acids to protect cardiomyocytes from hypoxia/anoxia.

  2008cited by this paper
• Soluble epoxide hydrolase and epoxyeicosatrienoic acids modulate two distinct analgesic pathways

  2008cited by this paper
• An essential role for SRC-activated STAT-3 in 14,15-EET-induced VEGF expression and angiogenesis.

  2008cited by this paper
• Epoxyeicosatrienoic acids are part of the VEGF-activated signaling cascade leading to angiogenesis.

  2008cited by this paper
• Soluble epoxide hydrolase is a susceptibility factor for heart failure in a rat model of human disease

  2008cited by this paper
• Regulation of Drug-Metabolizing Enzymes and Transporters in Infection, Inflammation, and Cancer

  2008cited by this paper
• Cytochrome P450 2C9-Induced Angiogenesis Is Dependent on EphB4

  2008cited by this paper
• Epoxygenases and peroxisome proliferator‐activated receptors in mammalian vascular biology

  2008cited by this paper
• Soluble Epoxide Hydrolase Gene Deletion Is Protective Against Experimental Cerebral Ischemia

  2008cited by this paper
• Soluble Epoxide Hydrolase Inhibitors Reduce the Development of Atherosclerosis in Apolipoprotein E-Knockout Mouse Model

  2008cited by this paper
• Cytochrome P450 (CYP) 2J2 gene transfection attenuates MMP‐9 via inhibition of NF‐κβ in hyperhomocysteinemia

  2008cited by this paper
• Soluble epoxide hydrolase inhibition and gene deletion are protective against myocardial ischemia-reperfusion injury in vivo.

  2008cited by this paper
• Role of epoxyeicosatrienoic acids in protecting the myocardium following ischemia/reperfusion injury.

  2007cited by this paper
• Sequence variation in the soluble epoxide hydrolase gene and subclinical coronary atherosclerosis: interaction with cigarette smoking.

  2007cited by this paper
• Mechanisms by which epoxyeicosatrienoic acids (EETs) elicit cardioprotection in rat hearts.

  2007cited by this paper
• Cytochrome P-450 epoxygenases protect endothelial cells from apoptosis induced by tumor necrosis factor-α via MAPK and PI3K/Akt signaling pathways

  2007cited by this paper
• Acute tissue-type plasminogen activator release in human microvascular endothelial cells: The roles of Gαq, PLC-β, IP3 and 5,6-epoxyeicosatrienoic acid

  2007cited by this paper
• Genetic variation in the cytochrome P450 epoxygenase pathway and cardiovascular disease risk.

  2007cited by this paper
• Heme Oxygenase-1 Expression in Macrophages Plays a Beneficial Role in Atherosclerosis

  2007cited by this paper
• Cytochrome p450 epoxygenase promotes human cancer metastasis.

  2007cited by this paper
• Compensatory Mechanism for Homeostatic Blood Pressure Regulation in Ephx2 Gene-disrupted Mice*

  2007cited by this paper
• CYP2J2 and CYP2C8 polymorphisms and coronary heart disease risk: the Atherosclerosis Risk in Communities (ARIC) study

  2007cited by this paper
• Angiotensin II up-regulates soluble epoxide hydrolase in vascular endothelium in vitro and in vivo

  2007cited by this paper
• Emerging mechanisms for growth and protection of the vasculature by cytochrome P450-derived products of arachidonic acid and other eicosanoids.

  2007cited by this paper
• Cytochrome P450 Eicosanoids are Activators of Peroxisome Proliferator-Activated Receptor α

  2007cited by this paper
• 11,12-Epoxyeicosatrienoic acid activates the l-arginine/nitric oxide pathway in human platelets

  2007cited by this paper
• Cytochrome P-450 epoxygenases protect endothelial cells from apoptosis induced by tumor necrosis factor-alpha via MAPK and PI3K/Akt signaling pathways.

  2007cited by this paper
• 11,12-epoxyeicosatrienoic acid stimulates heme-oxygenase-1 in endothelial cells.

  2007cited by this paper
• Acute tissue-type plasminogen activator release in human microvascular endothelial cells: the roles of Galphaq, PLC-beta, IP3 and 5,6-epoxyeicosatrienoic acid.

  2007cited by this paper
• Epoxyeicosatrienoic acids, cell signaling and angiogenesis.

  2007cited by this paper
• Protective effects of epoxyeicosatrienoic acids on human endothelial cells from the pulmonary and coronary vasculature.

  2006cited by this paper
• Role of Soluble Epoxide Hydrolase in Postischemic Recovery of Heart Contractile Function

  2006cited by this paper
• Genetic variation in soluble epoxide hydrolase (EPHX2) and risk of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) study.

  2006cited by this paper
• Tumor Necrosis Factor α Blockade Increases Renal Cyp2c23 Expression and Slows the Progression of Renal Damage in Salt-Sensitive Hypertension

  2006cited by this paper
• Rat mesenteric arterial dilator response to 11,12-epoxyeicosatrienoic acid is mediated by activating heme oxygenase.

  2006cited by this paper
• 14,15-Dihydroxyeicosatrienoic acid activates peroxisome proliferator-activated receptor-alpha.

  2006cited by this paper
• Endothelium : Signaling , Oxidative Stress , and Gene Expression Series

  2006cited by this paper
• Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors

  2006cited by this paper
• Epoxyeicosatrienoic and dihydroxyeicosatrienoic acids dilate human coronary arterioles via BK(Ca) channels: implications for soluble epoxide hydrolase inhibition.

  2006cited by this paper
• Fibroblast Growth Factor-2 Is a Downstream Mediator of Phosphatidylinositol 3-Kinase-Akt Signaling in 14,15-Epoxyeicosatrienoic Acid-induced Angiogenesis*

  2006cited by this paper
• Enhancement of antinociception by coadministration of nonsteroidal anti-inflammatory drugs and soluble epoxide hydrolase inhibitors

  2006cited by this paper
• From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions.

  2006cited by this paper
• Tumor necrosis factor alpha blockade increases renal Cyp2c23 expression and slows the progression of renal damage in salt-sensitive hypertension.

  2006cited by this paper
• Synergistic effect of cytochrome P450 epoxygenase CYP2J2*7 polymorphism with smoking on the onset of premature myocardial infarction.

  2006influential reference
• Epoxyeicosatrienoic acids in cardioprotection: ischemic versus reperfusion injury.

  2006cited by this paper
• Tobacco smoke dysregulates endothelial vasoregulatory transcripts in vivo.

  2005cited by this paper
• The antiinflammatory effect of laminar flow: the role of PPARgamma, epoxyeicosatrienoic acids, and soluble epoxide hydrolase.

  2005influential reference
• Attenuation of tobacco smoke-induced lung inflammation by treatment with a soluble epoxide hydrolase inhibitor.

  2005cited by this paper
• Decreased epoxygenase and increased epoxide hydrolase expression in the mesenteric artery of obese Zucker rats.

  2005cited by this paper
• The soluble epoxide hydrolase gene harbors sequence variation associated with susceptibility to and protection from incident ischemic stroke.

  2005cited by this paper
• Activation of Peroxisome Proliferator-Activated Receptor α by Substituted Urea-Derived Soluble Epoxide Hydrolase Inhibitors

  2005cited by this paper
• An Epoxide Hydrolase Inhibitor, 12-(3-Adamantan-1-yl-ureido)dodecanoic Acid (AUDA), Reduces Ischemic Cerebral Infarct Size in Stroke-Prone Spontaneously Hypertensive Rats

  2005cited by this paper
• Soluble epoxide hydrolase is a therapeutic target for acute inflammation.

  2005influential reference
• Nuclear factor kappaB signaling in atherogenesis.

  2005cited by this paper
• Characterization of 5,6- and 8,9-Epoxyeicosatrienoic Acids (5,6- and 8,9-EET) as Potent in Vivo Angiogenic Lipids*

  2005cited by this paper
• Eicosapentaenoic acid metabolism by cytochrome P450 enzymes of the CYP2C subfamily.

  2005cited by this paper
• Cytochrome P450 epoxygenases 2C8 and 2C9 are implicated in hypoxia-induced endothelial cell migration and angiogenesis

  2005cited by this paper
• Arachidonic Acid Epoxygenase Metabolites Stimulate Endothelial Cell Growth and Angiogenesis via Mitogen-Activated Protein Kinase and Phosphatidylinositol 3-Kinase/Akt Signaling Pathways

  2005cited by this paper
• Membrane Potential-Dependent Inhibition of Platelet Adhesion to Endothelial Cells by Epoxyeicosatrienoic Acids

  2004cited by this paper
• Inhibition of Cytochrome P450 2C9 Improves Endothelium-Dependent, Nitric Oxide–Mediated Vasodilatation in Patients With Coronary Artery Disease

  2004cited by this paper
• Laminar Flow Activates Peroxisome Proliferator–Activated Receptor-&ggr; in Vascular Endothelial Cells

  2004cited by this paper
• A peroxisome proliferator-activated receptor-alpha activator induces renal CYP2C23 activity and protects from angiotensin II-induced renal injury.

  2004cited by this paper
• Polymorphism of the Soluble Epoxide Hydrolase Is Associated With Coronary Artery Calcification in African-American Subjects: The Coronary Artery Risk Development In Young Adults (CARDIA) Study

  2004cited by this paper
• Excess nitric oxide decreases cytochrome P-450 2J4 content and P-450-dependent arachidonic acid metabolism in lungs of rats with acute pneumonia.

  2004cited by this paper
• Distribution of Soluble Epoxide Hydrolase and of Cytochrome P450 2C8, 2C9, and 2J2 in Human Tissues

  2004cited by this paper
• Enhanced Postischemic Functional Recovery in CYP2J2 Transgenic Hearts Involves Mitochondrial ATP-Sensitive K+ Channels and p42/p44 MAPK Pathway

  2004cited by this paper
• Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function.

  2004cited by this paper
• Transcriptional suppression of cytochrome P450 genes by endogenous and exogenous chemicals.

  2004cited by this paper
• Risk of Coronary Artery Disease Associated With Polymorphism of the Cytochrome P450 Epoxygenase CYP2J2

  2004cited by this paper
• Reduction of ischemia and reperfusion-induced myocardial damage by cytochrome P450 inhibitors.

  2004cited by this paper
• Non-prostaglandin eicosanoids in fever and anapyrexia.

  2004cited by this paper
• Differential expression of cytochrome P450 isoforms in the lungs of septic animals

  2004cited by this paper
• Cytochrome P4502C9-Derived Epoxyeicosatrienoic Acids Induce the Expression of Cyclooxygenase-2 in Endothelial Cells

  2004influential reference
• Downregulation of Renal CYP-Derived Eicosanoid Synthesis in Rats With Diet-Induced Hypertension

  2003cited by this paper
• Polymorphisms in human soluble epoxide hydrolase.

  2003cited by this paper
• Allelic variants of cytochromes P450 2C modify the risk for acute myocardial infarction.

  2003cited by this paper
• TNF-alpha -induced endothelial cell adhesion molecule expression is cytochrome P-450 monooxygenase dependent.

  2003cited by this paper
• Pulmonary cytochrome P-450 2J4 is reduced in a rat model of acute Pseudomonas pneumonia.

  2003cited by this paper
• Up-Regulation of Endothelial Nitric-Oxide Synthase by Endothelium-Derived Hyperpolarizing Factor Involves Mitogen-Activated Protein Kinase and Protein Kinase C Signaling Pathways

  2003cited by this paper
• 12-Epoxyeicosatrienoic Acid-induced Inhibition of FOXO Factors Promotes Endothelial Proliferation by Down-Regulating p 27 Kip 1 *

  2003cited by this paper
• Role of epoxyeicosatrienoic acids in renal functional response to inhibition of NO production in the rat.

  2003cited by this paper
• Epoxygenase-driven angiogenesis in human lung microvascular endothelial cells.

  2003cited by this paper
• 11,12-Epoxyeicosatrienoic Acid-induced Inhibition of FOXO Factors Promotes Endothelial Proliferation by Down-Regulating p27Kip1*

  2003cited by this paper
• Decreased Renal Cytochrome P450 2C Enzymes and Impaired Vasodilation Are Associated With Angiotensin Salt-Sensitive Hypertension

  2003cited by this paper
• Cytochrome P450 2C9‐derived epoxyeicosatrienoic acids induce angiogenesis via cross‐talk with the epidermal growth factor receptor

  2003cited by this paper
• Medicine. PPARs as therapeutic targets: reverse cardiology?

  2003cited by this paper
• 11,12-Epoxyeicosatrienoic Acid Attenuates Synthesis of Prostaglandin E2 in Rat Monocytes Stimulated with Lipopolysaccharide

  2003cited by this paper
• 11,12-epoxyeicosatrienoic acid (11,12-EET): structural determinants for inhibition of TNF-alpha-induced VCAM-1 expression.

  2003cited by this paper
• PPARs as Therapeutic Targets: Reverse Cardiology?

  2003cited by this paper

• Epoxy-oxylipins direct monocyte fate in inflammatory resolution in humans

  2026cites this paper
• Study on the mechanism of Xanthoceras sorbifolia Bunge oil in the treatment of Alzheimer’s disease by an integrated “network pharmacology-metabolomics” strategy

  2025cites this paper
• Soluble Epoxide Hydrolase Inhibition Confers Neuroprotection via PPAR‐α Activation During Intracerebral Hemorrhage

  2025cites this paper
• Synthetic Epoxyeicosatrienoic Acid Mimics Protect Mesangial Cells from Sorafenib-Induced Cell Death

  2025cites this paper
• QM/MM study of cytochrome P450 TxtE catalysis: Substrate reorganization enables selective aromatic nitration.

  2025cites this paper
• Molecular mechanisms of cytochrome P450-derived epoxy-fatty acids neuroprotection.

  2025cites this paper
• Effects of resveratrol on CYP450-derived arachidonic acid metabolites and mRNA gene expression in human endothelial HUVEC cells

  2025cites this paper
• Reprogramming Inflammation: Mechanisms and Therapeutic Targeting of Eicosanoids and Pro-Resolving Mediators.

  2025cites this paper
• Sciadonic Acid–Rich Torreya grandis Oil Improves Hepatic Steatosis via PPARα Activation and Arachidonic-Acid Remodeling

  2025cites this paper
• Mechanistic Perspective on C–N and C–S Bond Construction Catalyzed by Cytochrome P450 Enzymes

  2024cites this paper
• Urine LMs quantitative analysis strategy development and LMs CWP biomarkers discovery.

  2024cites this paper
• Epoxyeicosatrienoic Acids Attenuate LPS-Induced NIH/3T3 Cell Fibrosis through the A2AR and PI3K/Akt Signaling Pathways

  2024cites this paper
• Cardioprotective Response and Senescence in Aged sEH Null Female Mice Exposed to LPS.

  2024cites this paper
• The Role of Arachidonic Acid Metabolizing Cytochromes P450 in the Control of Cardiovascular Functions

  2024cites this paper
• Bazi Bushen ameliorates age-related energy metabolism dysregulation by targeting the IL-17/TNF inflammatory pathway associated with SASP

  2024cites this paper
• Genetic variants in epoxyeicosatrienoic acid processing and degradation pathways are associated with gestational diabetes mellitus

  2023influential citation
• Dihydroxy-Metabolites of Dihomo-γ-linolenic Acid Drive Ferroptosis-Mediated Neurodegeneration

  2023cites this paper
• Plasma oxidative lipidomics reveals signatures for sepsis-associated acute kidney injury.

  2023cites this paper
• Integration of plasma and CSF metabolomics with CSF proteomic reveals novel associations between lipid mediators and central nervous system vascular and energy metabolism

  2023cites this paper
• Dihydroxy-Metabolites of Dihomo-gamma-linolenic Acid Drive Ferroptosis-Mediated Neurodegeneration

  2023cites this paper
• How the Conformational Movement of the Substrate Drives the Regioselective C-N Bond Formation in P450 TleB: Insights from Molecular Dynamics Simulations and Quantum Mechanical/Molecular Mechanical Calculations.

  2023cites this paper
• Effects of Arachidonic Acid and Its Metabolites on Functional Beta-Cell Mass

  2022cites this paper
• Effects of Erchen Decoction on Oxidative Stress-Related Cytochrome P450 Metabolites of Arachidonic Acid in Dyslipidemic Mice with Phlegm-Dampness Retention Syndrome: A Randomized, Controlled Trial on the Correspondence between Prescription and Syndrome

  2022cites this paper
• Effect of inflammation on cytochrome P450-mediated arachidonic acid metabolism and the consequences on cardiac hypertrophy

  2022influential citation
• Integration of proteomics and metabolomics - insights into inflammation, metabolic dysregulation, and vascular aspects in AD

  2022cites this paper
• Molecular aspects of neuroinflammation: Contribution of eicosanoids, cytokines, and chemokines

  2022cites this paper
• Discovery and Optimization of Indoline-Based Compounds as Dual 5-LOX/sEH Inhibitors: In Vitro and In Vivo Anti-Inflammatory Characterization

  2022cites this paper
• Anandamide and other N-acylethanolamines: A class of signaling lipids with therapeutic opportunities.

  2022cites this paper
• Soluble epoxide hydrolase inhibitor, TPPU, attenuates progression of atherosclerotic lesions and vascular smooth muscle cell phenotypic switching.

  2022cites this paper
• Upregulation of Beta 1 and Arachidonic acid Metabolizing Enzymes in the mouse Hearts and Kidneys after Sub chronic Administration of Rofecoxib.

  2022cites this paper
• Association of plasma and CSF cytochrome P450, soluble epoxide hydrolase, and ethanolamide metabolism with Alzheimer’s disease

  2021cites this paper
• Association of plasma and CSF cytochrome P450, soluble epoxide hydrolase and ethanolamides metabolism with Alzheimer’s disease

  2021cites this paper
• Differential Contribution of Renal Cytochrome P450 Enzymes to Kidney Endothelial Dysfunction and Vascular Oxidative Stress in Obesity.

  2021cites this paper
• Epoxyeicosatrienoic Acids Prevent Cardiomyocytes against Sepsis by A2AR-induced Activation of PI3K and PPARγ.

  2021cites this paper
• sEH promotes macrophage phagocytosis and lung clearance of Streptococcus pneumoniae.

  2021cites this paper
• Metformin Affects Cardiac Arachidonic Acid Metabolism and Cardiac Lipid Metabolite Storage in a Prediabetic Rat Model

  2021cites this paper
• Screening and Identification of Epoxy/Dihydroxy-Oxylipins by Chemical Labeling-Assisted Ultrahigh-Performance Liquid Chromatography Coupled with High-Resolution Mass Spectrometry.

  2021cites this paper
• Dihydroxyeicosatrienoic Acid, a Metabolite of Epoxyeicosatrienoic Acids Upregulates Endothelial Nitric Oxide Synthase Expression Through Transcription: Mechanism of Vascular Endothelial Function Protection

  2021cites this paper
• Plasma and urinary concentrations of arachidonic acid-derived eicosanoids are associated with diabetic kidney disease

  2021cites this paper
• Roles of Genetic Predisposition in the Sex Bias of Pulmonary Pathophysiology, as a Function of Estrogens : Sex Matters in the Prevalence of Lung Diseases.

  2021cites this paper
• Association of plasma and CSF cytochrome P450, soluble epoxide hydrolase and ethanolamides metabolism with Alzheimer's disease

  2021cites this paper
• Sexual Dimorphism in Doxorubicin-induced Systemic Inflammation: Implications for Hepatic Cytochrome P450 Regulation

  2020cites this paper
• The contribution of chymase-dependent formation of AngII to cardiac dysfunction in metabolic syndrome of young rats: roles of fructose and EETs.

  2020cites this paper
• Cytochrome P450-derived linoleic acid metabolites EpOMEs and DiHOMEs: A review of recent studies.

  2020cites this paper
• Cytochrome P450 1A1 enhances inflammatory responses and impedes phagocytosis of bacteria in macrophages during sepsis

  2020cites this paper
• The Role of Arachidonic Acid Metabolism in Myocardial Ischemia–Reperfusion Injury

  2020cites this paper
• Application of a novel analytical pipeline for high-dimensional multivariate mediation analysis of environmental data

  2020cites this paper
• Combination of Panax notoginseng saponins and aspirin potentiates platelet inhibition with alleviated gastric injury via modulating arachidonic acid metabolism.

  2020cites this paper
• CYP1B1 as a therapeutic target in cardio-oncology

  2020cites this paper
• Application of an analytical framework for multivariate mediation analysis of environmental data

  2020cites this paper
• Cytochrome P450-Derived Eicosanoids and Inflammation in Liver Diseases.

  2019cites this paper
• Nox4 and soluble epoxide hydrolase synergistically mediate homocysteine-induced inflammation in vascular smooth muscle cells.

  2019cites this paper
• Increased Soluble Epoxide Hydrolase in Human Gestational Tissues from Pregnancies Complicated by Acute Chorioamnionitis

  2019cites this paper
• Soluble epoxide hydrolase in the human placenta throughout gestation.

  2019cites this paper
• Vascular repair and anti-inflammatory effects of soluble epoxide hydrolase inhibitor

  2019cites this paper
• Dose-dependency of the cardiovascular risks of non-steroidal anti-inflammatory drugs

  2019cites this paper
• Overview of the Components of Cardiac Metabolism

  2019cites this paper
• AUDA as a modulator of lipid profile and endothelial function in diet induced hypercholesterolemia in rats

  2019cites this paper
• Epoxyeicosatrienoic acids alleviate methionine‐choline‐deficient diet–induced non‐alcoholic steatohepatitis in mice

  2019cites this paper
• CYP2J2/EET reduces vulnerability to atrial fibrillation in chronic pressure overload mice

  2019cites this paper
• Deficiency of Soluble Epoxide Hydrolase Protects Cardiac Function Impaired by LPS-Induced Acute Inflammation

  2019cites this paper
• Biologically Active Lipids in Vascular Biology

  2019cites this paper
• Epoxyeicosatrienoic acids protect pancreatic beta cells against pro-inflammatory cytokine toxicity.

  2019cites this paper
• Symposium review: Oxylipids and the regulation of bovine mammary inflammatory responses.

  2018cites this paper
• Protective effect of fenofibrate against ischemia‐/reperfusion‐induced cardiac arrhythmias in isolated rat hearts

  2018cites this paper
• An improved Ultra-High Performance Liquid chromatography-tandem mass spectrometry method for simultaneous quantitation of cytochrome P450 metabolites of arachidonic acid in human plasma.

  2018cites this paper
• Association between the EPHX2 p.Lys55Arg polymorphism and prognosis following an acute coronary syndrome.

  2018cites this paper
• A sensitive and improved throughput UPLC-MS/MS quantitation method of total cytochrome P450 mediated arachidonic acid metabolites that can separate regio-isomers and cis/trans-EETs from human plasma.

  2018cites this paper
• Lipid profiling in serum from apolipoprotein E-knock out mice fed with different diets and its application to the study of the regulatory effect on lipid metabolism.

  2018cites this paper
• The immune-metabolic regulatory roles of epoxyeicosatrienoic acids on macrophages phenotypic plasticity in obesity-related insulin resistance.

  2018cites this paper
• Downregulated Serum 14, 15-Epoxyeicosatrienoic Acid Is Associated With Abdominal Aortic Calcification in Patients With Primary Aldosteronism

  2018cites this paper
• Increased epoxyeicosatrienoic acids may be part of a protective mechanism in human ulcerative colitis, with increased CYP2J2 and reduced soluble epoxide hydrolase expression.

  2018cites this paper
• Effects of Farnesoid X Receptor Activation on Arachidonic Acid Metabolism, NF-kB Signaling, and Hepatic Inflammation

  2018cites this paper
• Cytochrome P450 in the central nervous system as a therapeutic target in neurodegenerative diseases

  2018influential citation
• CYP1B1: A key regulator of redox homeostasis.

  2018cites this paper
• Spatial learning and memory in brain-injured and non-injured mice: investigating the roles of diacylglycerol lipase-α and -β.

  2018cites this paper
• Translational evaluation of cytochrome P450-derived epoxyeicosanoids in non-alcoholic steatohepatitis (NASH)

  2017influential citation
• Eicosanoids and exosomes : a link between macrophages and lung cancer

  2017cites this paper
• Association between the soluble epoxide hydrolase gene and preeclampsia

  2017cites this paper
• Cytochrome P450‐derived eicosanoids and heart function

  2017cites this paper
• Ophiopogonin D and EETs ameliorate Ang II-induced inflammatory responses via activating PPARα in HUVECs.

  2017cites this paper
• The roles of cytochromes P 450 in vascular biology and cardiovascular homeostasis

  2017cites this paper
• The Physiopathology of Cardiorenal Syndrome: A Review of the Potential Contributions of Inflammation

  2017cites this paper
• Endothelial Nox4-based NADPH oxidase regulates atherosclerosis via soluble epoxide hydrolase.

  2017cites this paper
• P450 Eicosanoids and Reactive Oxygen Species Interplay in Brain Injury and Neuroprotection

  2017cites this paper
• EETs reduces LPS-induced hyperpermeability by targeting GRP78 mediated Src activation and subsequent Rho/ROCK signaling pathway

  2017cites this paper
• Ischemia/Reperfusion.

  2017cites this paper
• Cytochrome P450 eicosanoids in cerebrovascular function and disease

  2017cites this paper
• EETs reduces LPS-induced hyperpermeability by targeting GRP78 mediated Src activation and subsequent Rho/ROCK signaling pathway.

  2017cites this paper
• Effect of a Soluble Epoxide Hydrolase Inhibitor , UC 1728 , on LPS-Induced Uveitis in the Rabbit Abbreviations

  2016cites this paper
• Soluble epoxide hydrolase deficiency or inhibition enhances murine hypoxic pulmonary vasoconstriction after lipopolysaccharide challenge.

  2016influential citation
• Exported Epoxide Hydrolases Modulate Erythrocyte Vasoactive Lipids during Plasmodium falciparum Infection

  2016cites this paper
• Cigarette Smoke-Induced Pulmonary Inflammation and Autophagy Are Attenuated in Ephx2-Deficient Mice

  2016cites this paper
• Pro-atherogenic role of smooth muscle Nox4-based NADPH oxidase.

  2016cites this paper
• Characterization of the Cytochrome P450 epoxyeicosanoid pathway in non-alcoholic steatohepatitis.

  2016cites this paper
• Effect of a Soluble Epoxide Hydrolase Inhibitor, UC1728, on LPS-Induced Uveitis in the Rabbit

  2016cites this paper
• Cytochrome P450 genes in coronary artery diseases: Codon usage analysis reveals genomic GC adaptation.

  2016cites this paper
• Single administration of soluble epoxide hydrolase inhibitor suppresses neuroinflammation and improves neuronal damage after cardiac arrest in mice.

  2016cites this paper
• Effect of Subtotal Renal Nephrectomy on CYP450-Mediated Metabolism of Arachidonic Acid: A Potential Player in Pathogenesis of Renocardiac Syndrome?

  2016cites this paper
• Activation of complement factor B contributes to murine and human myocardial ischemia/reperfusion injury

  2016cites this paper